Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2753-2760, December 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oakes, D. D.
Right arrow Articles by Gold, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oakes, D. D.
Right arrow Articles by Gold, P.

Radioimmunoassay for {alpha}1-Fetoprotein in the Serum of Rats1

David D. Oakes, Joseph Shuster2 and Phil Gold3

The Division of Clinical Immunology and Allergy and the McGill University Medical Clinic of the Montreal General Hospital, Montreal, 109, Quebec, Canada

A radioimmunoassay for the detection of {alpha}1-fetoprotein (AFP) in the sera of rats is described. The procedure is based on the preparation of purified and radiolabeled AFP, monospecific anti-AFP antiserum, and a modification of the coprecipitation-inhibition technique in 50% saturated ammonium sulfate. A detailed description is given of the combination of immunochemical and physiocochemical methods used in the purification of the rat AFP. The purified rat AFP is virtually identical to the native, circulating AFP by immunological criteria and contains, at most, trace contamination with other materials. The radioimmunoassay has a sensitivity that allows 25 ng AFP per ml of serum to be detected with reproducibility. The assay requires 20 µl of serum for analysis and can be completed within a few hours.

1 Supported by a grant from the Medical Research Council of Canada, Ottawa, Ontario, Canada.

2 Scholar of the Medical Research Council of Canada.

3 Associate of the Medical Research Council of Canada.

Received 7/10/72. Accepted 9/ 5/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.